The landscape of tumor treatment is constantly evolving, with a growing emphasis on identifying novel therapeutic targets for drug synthesis. Traditional therapies often strike rapidly dividing cells, leading to significant side effects. However, the emergence of sophisticated genomic profiling techniques has altered our understanding of cancer bio